A Study Based on CT Radiomics for Distinguishing Benign From Malignant Renal Tumors and Assessing Their Aggressiveness.
Active, not recruitingOBSERVATIONAL
Enrollment
700
Participants
Timeline
Start Date
January 1, 2025
Primary Completion Date
June 30, 2027
Study Completion Date
June 30, 2027
Conditions
Renal Cell Carcinoma (RCC)
Trial Locations (1)
Unknown
Second Xiangya Hospital, Changsha
All Listed Sponsors
lead
Second Xiangya Hospital of Central South University
OTHER
NCT07060248 - A Study Based on CT Radiomics for Distinguishing Benign From Malignant Renal Tumors and Assessing Their Aggressiveness. | Biotech Hunter | Biotech Hunter